TRACI MORRISON: Open Payments
NPI 1245593136 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 35 payments from 23 companies in 2025. Trend: 2023 $817 · 2024 $934 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| GENZYME CORPORATION | 1 | $80 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| ABBVIE INC. | 3 | $45 |
| Karyopharm Therapeutics Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| PFIZER INC. | 2 | $40 |
| Deciphera Pharmaceuticals Inc. | 1 | $32 |
| ARRAY BIOPHARMA INC | 1 | $29 |
Products named: SARCLISA, OPDIVO, KEYTRUDA, EPKINLY, XPOVIO, OJJAARA, SCEMBLIX, QINLOCK.
Industry payments across AL — which companies pay providers there.
